CorMedix Newsroom

Buy Rating on Cormedix Affirmed Amidst DefenCath's Strong Market Entry and Growth Prospects

TipRanksSep 10 01:37

JMP Securities Maintains CorMedix(CRMD.US) With Buy Rating, Maintains Target Price $19

Futu NewsSep 10 01:32

Rodman & Renshaw Initiates CorMedix(CRMD.US) With Buy Rating, Announces Target Price $13

Futu NewsAug 26 19:31

CorMedix Price Target Announced at $13.00/Share by Rodman & Renshaw

Dow JonesAug 26 19:16

Rodman & Renshaw Initiates Coverage On Cormedix With Buy Rating, Announces Price Target of $13

BenzingaAug 26 19:06

Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating

Futu NewsAug 15 23:31

A Quick Look at Today's Ratings for CorMedix(CRMD.US), With a Forecast Between $9 to $19

Futu NewsAug 15 21:00

Cormedix (CRMD) Gets a Buy From Truist Financial

TipRanksAug 15 20:43

Needham Reiterates Buy on Cormedix, Maintains $10 Price Target

BenzingaAug 15 17:37

Cormedix Analyst Ratings

BenzingaAug 15 17:37

CorMedix Price Target Cut to $12.00/Share From $14.00 by Truist Securities

Dow JonesJul 25 22:59

Truist Securities Maintains Buy on Cormedix, Lowers Price Target to $12

BenzingaJul 25 22:51

Cormedix Analyst Ratings

BenzingaJul 25 22:51

Truist Financial Maintains CorMedix(CRMD.US) With Buy Rating, Cuts Target Price to $12

Futu NewsJul 25 21:53

Cormedix Analyst Ratings

BenzingaJun 19 17:47

Needham Reiterates Buy on Cormedix, Maintains $10 Price Target

BenzingaJun 19 17:46

Needham: Reiterates Cormedix (CRMD.US) rating and adjusted from buy to buy rating, target price is $10.00.

Zhitong FinanceMay 13 17:40

Cormedix Analyst Ratings

BenzingaMay 13 17:35

Needham Reiterates Buy on Cormedix, Maintains $10 Price Target

BenzingaMay 13 17:35

Analysts' Opinions Are Mixed on These Healthcare Stocks: Beam Therapeutics (BEAM), Cormedix (CRMD) and Applied Therapeutics (APLT)

TipRanksMay 11 09:55